← All organizations
National Institute of Child Health and Human Development (NICHD)
GovernmentWebsite ↗
Also known as: Ann Davis, PhD, MPH, ABPP | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | NICHD Director | NICHD Global Network for Women's and Children's Health | NICHD Neonatal Research Network
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1988Last known activity
Jun 30, 2025
Timeline
1960s
- Jan 1, 1962
National Institute of Child Health and Human Development (NICHD)— Founded
Drugs by trial phase (72 distinct, 69 trials)
Phase 4 (19 own, 0 via acquisition)
Phase 3 (31 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Anemia, Neonatal
- Apnea
- Arthritis
- Arthritis, Juvenile
- Birth Weight
- Body Weight
- Bronchopulmonary Dysplasia
- Cleft Lip
- Cleft Palate
- Death
- Ductus Arteriosus, Patent
- Eclampsia
- Emergencies
- Enuresis
- Fecal Incontinence
- Genetic Diseases, X-Linked
- HELLP Syndrome
- Hemorrhage
- Hernia
- Hernia, Diaphragmatic
- Hernias, Diaphragmatic, Congenital
- HIV Infections
- HIV Seropositivity
- Hyperinsulinism
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertelorism
- Hypertension
- Hypertension, Pulmonary
- Hypospadias
- Hypotension
- Infant, Newborn, Diseases
- Infections
- Insulin Resistance
- Intracranial Hemorrhages
- Leiomyoma
- Lung Diseases
- Malaria
- Malnutrition
- Maternal Death
- Meningitis
- Myofibroma
- Neonatal Sepsis
- Obesity
- Perinatal Death
- Persistent Fetal Circulation Syndrome
- Pneumonia
- Pneumonia, Aspiration
- Pneumonia, Pneumocystis
- Pre-Eclampsia
- Pregnancy Complications, Infectious
- Premature Birth
- Puerperal Infection
- Pulmonary Valve Insufficiency
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Retinal Diseases
- Retinopathy of Prematurity
- Sepsis
- Smith-Lemli-Opitz Syndrome
- Streptococcal Infections
- Syndrome
- Toxemia
- Tuberculosis
- Urinary Bladder, Overactive
- Urinary Incontinence
- Urinary Incontinence, Urge
Recent trials (50)
- NCT06723392Lead sponsorPhase 1Jun 30, 2025
- NCT06855108Lead sponsorPhase 3Jun 30, 2025
- NCT06679855Lead sponsorPhase 3Feb 1, 2025
- NCT05539989Lead sponsorPhase 1/Phase 2Mar 31, 2023
- NCT05590260Lead sponsorPhase 3Jan 1, 2023
- NCT04545866Lead sponsorPhase 3Dec 31, 2020
- NCT04518228CollaboratorPhase 4Oct 15, 2020
- NCT03871491Lead sponsorPhase 3Aug 1, 2019
- NCT03340727Lead sponsorPhase 3Oct 31, 2018
- NCT03537768Study directorPhase 4Jul 12, 2018
- NCT03169881Lead sponsorPhase 3Sep 1, 2017
- NCT02951130Lead sponsorPhase 2Jun 1, 2017
- NCT03032367Lead sponsorEarly Phase 1Nov 10, 2016
- NCT02409680Lead sponsorN/AMar 1, 2016
- NCT02409680Study directorN/AMar 1, 2016
Details
- Founded
- Rockville, MD, US Jan 1, 1962
- Last known activity
- Jun 30, 2025